Annual report pursuant to Section 13 and 15(d)

10. Stockholders' Equity (Details Narrative)

10. Stockholders' Equity (Details Narrative) - USD ($)	2 Months Ended	6 Months Ended		7 Months Ended		12 Months Ended
10. Stockholders' Equity (Details Narrative) - USD ($)	Mar. 05, 2019	Jul. 03, 2019	Jun. 25, 2019	Jul. 17, 2019	Jul. 16, 2019	Dec. 31, 2019	Dec. 31, 2018	Jun. 28, 2019
Reverse stock split			1-for-12 reverse stock split
Reverse stock split, shares			1,442
Net proceeds from issuance of common stock and warrants in public offering						$ 13,421,950	$ 0
Net proceeds from issuance of common stock and warrants in registered direct offering						$ 2,699,050	0
Stock outstanding						6,065,441
Proceeds from warrants exercised						$ 6,209	1,480,000
Deemed dividend related to Series B Preferred Stock down round provision, value						$ 5,284,379	$ 0
Preferred stock authorized						10,000,000	10,000,000
Share-based compensation						$ 806,090	$ 1,362,079
General and administrative expense						$ 4,731,176	$ 4,392,375
Warrants [Member]
Warrants outstanding						32,412	44,944
Non-Affiliates [Member]
Stock outstanding								475,000
SynBio [Member] \| Warrants [Member]
Share-based compensation						$ 0	$ 10,000
Series B Preferred Stock [Member]
Stock converted, shares converted						0	316,000
Stock converted, shares issued						0	26,000
Preferred stock authorized						2,500,000
Preferred stock liquidation preference per share						$ 4.00
If converted, common stock issuable						600,000	300,000
Series B Preferred Stock [Member] \| Down Round Provision [Member]
Deemed dividend related to Series B Preferred Stock down round provision, value						$ 1,400,000
Warrants [Member]
Warrants exercised, shares							31,000
Common stock issued for exercise of cashless warrant							$ 31,000
Series A Preferred Stock [Member]
Preferred stock authorized						1,000,000
Preferred stock par value						$ 0.001
Preferred stock liquidation preference per share						$ 4.80
If converted, common stock issuable						80,834
Consent Warrants [Member] \| Certain Holders of Warrants [Member]
Warrants issued		8,335
Warrant exercise price		$ 10.63				$ 2.91
Grant date fair value of warrants per share		$ 7.62
Warrants granted fair value		$ 64,000
Fair value adjustment of warrants						$ 2,000
General and administrative expense						$ 64,000
Outstanding debt and equity financing warrants [Member]
Warrants exercised, shares						0	31,000
Proceeds from warrants exercised							$ 1,500,000
Warrants outstanding						262,690	262,690
Warrants weighted average exercise price						$ 51.97
Underwriting Agreement [Member]
Gross proceeds form the sale of stock and warrants				$ 15,000,000
Net proceeds from issuance of common stock and warrants in public offering				$ 13,400,000
Underwriting Agreement [Member] \| Shares [Member]
Stock issued new, shares				1,730,000
Underwriting Agreement [Member] \| Prefunded Warrants [Member]
Stock issued new, shares				570,000
Warrant exercise price				$ 0.01
Proceeds from warrants exercised						$ 5,700
Intrinsic value of warrants				$ 3,100,000
Underwriting Agreement [Member] \| Purchase Warrants [Member]
Warrants issued				2,300,000
Warrant exercise price				$ 13.00
Warrant term				5 years
Grant date fair value of warrants per share				$ 4.61
Warrants exercised, shares						2,200,000
Warrants granted fair value				$ 11,300,000
Underwriting Agreement [Member] \| Purchase Warrants [Member] \| Underwriter [Member]
Warrants exercised, shares				160,000
Proceeds from warrants exercised				$ 1,600
Underwriting Agreement [Member] \| Share and Prefunded Warrant [Member]
Warrant exercise price				$ 6.50
Underwriting Agreement [Member] \| Prefunded Warrant and Purchase Warrant [Member]
Warrant exercise price				$ 6.49
Underwriting Agreement [Member] \| Additional Securities [Member]
Stock issued new, shares				345,000
Underwriting Agreement [Member] \| Consent Shares [Member] \| Certain Holders of Warrants [Member]
Stock issued new, shares					16,666
Securities Purchase Agreement [Member]
Net proceeds from issuance of common stock and warrants in registered direct offering	$ 2,700,000
Securities Purchase Agreement [Member] \| Prefunded Warrants [Member]
Warrants issued	42,417
Warrant exercise price	$ 0.012
Stock sale price	$ 23.988
Proceeds from warrants exercised						$ 509
Intrinsic value of warrants	$ 1,100,000
Securities Purchase Agreement [Member] \| Common Stock [Member]
Stock issued new, shares	86,667
Stock sale price	$ 24.00
Private Placement [Member] \| Purchasers [Member]
Warrant exercise price	$ 27.00
Warrant term	7 years
Grant date fair value of warrants per share	$ 22.74
Warrants granted fair value	$ 2,900,000
March 2019 Direct Offering [Member] \| Series B Preferred Stock [Member]
Deemed dividend related to Series B Preferred Stock down round provision, value						$ 3,900,000
Direct Offering [Member] \| Prefunded Warrants [Member]
Warrants issued				570,000
Warrant exercise price				$ 0.01
Stock sale price				6.49
Warrants exercised, shares						570,000
Proceeds from warrants exercised						$ 5,700
Direct Offering [Member] \| Purchase Warrants [Member]
Warrant exercise price				$ 13.00
Warrant term				5 years
Warrants outstanding						258,000
Common stock issued for exercise of cashless warrant						$ 2,200,000